IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
15 hedge funds and large institutions have $3.9M invested in Interpace Biosciences, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$435K | |
| 2 | +$57K | |
| 3 | +$6K | |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$2.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$15 |
Top Sellers
| 1 | -$43K | |
| 2 | -$28.4K | |
| 3 | -$27K | |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$13K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$10K |